We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Invitrogen Launches Biomarker Tool for Pre-Clinical Research into Kidney Function
Product News

Invitrogen Launches Biomarker Tool for Pre-Clinical Research into Kidney Function

Invitrogen Launches Biomarker Tool for Pre-Clinical Research into Kidney Function
Product News

Invitrogen Launches Biomarker Tool for Pre-Clinical Research into Kidney Function


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Invitrogen Launches Biomarker Tool for Pre-Clinical Research into Kidney Function"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Invitrogen has announced the global availability of a new biomarker tool for use in pre-clinical research into kidney function. The PlexMark™ 3 Renal Biomarker Panel Assay is a non-invasive and cost-effective research tool for performing post-transplantation kidney function studies.

The introduction of this research tool will help in the development of studies which may lead to more effective methods for monitoring kidney health in transplant research, the company expects.

This new assay provides researchers with an alternative to invasive and expensive procedures, such as biopsies, used to obtain kidney tissue samples to allow research into post-transplantation kidney function.

The PlexMark 3 Renal Biomarker Panel Assay measures levels of cytokines, chemokines and receptor levels in urine, which can give researchers a better understanding of immune function and response. This may lead to the development of new, non-invasive tests to monitor kidney function and health following transplant procedures.

The PlexMark assay uses Luminex® xMAP® multiplexing technology for bioassay analysis, in a standard immunoassay format to offer sensitivity and reproducible results. The biomarkers in the PlexMark panel are licensed from Renovar Inc, a developer of new tools for assessing kidney inflammation for numerous clinical indications.
Advertisement